Aloimune • Imunologia da Reprodução

71 3235-0958 • 99197-8344

Espaço Científico

Encontre conteúdos relacionados à área de Medicina Fetal, Imunologia da Reprodução e assuntos ligados a área de fertilidade em geral.
Home » Espaço Científico
Compartilhe:
parto-prematuro

11 de setembro de 2015

Progesterona reduz parto prematuro

Eduardo B. Fonseca, M.D., Ebru Celik, M.D., Mauro Parra, M.D.,

Mandeep Singh, M.D., and Kypros H. Nicolaides, M.D.,

for the Fetal Medicine Foundation Second Trimester Screening Group

BACKGROUND

Previous randomized trials have shown that progesterone administration in women who previously delivered prematurely reduces the risk of recurrent premature delivery. Asymptomatic women found at midgestation to have a short cervix are at greatly increased risk for spontaneous early preterm delivery, and it is unknown whether progesterone reduces this risk in such women.

METHODS

Cervical length was measured by transvaginal ultrasonography at a median of 22 weeks of gestation (range, 20 to 25) in 24,620 pregnant women seen for routine prenatal care. Cervical length was 15 mm or less in 413 of the women (1.7%), and 250 (60.5%) of these 413 women were randomly assigned to receive vaginal progesterone (200 mg each night) or placebo from 24 to 34 weeks of gestation. The primary outcome was spontaneous delivery before 34 weeks.

RESULTS

Spontaneous delivery before 34 weeks of gestation was less frequent in the progesterone group than in the placebo group (19.2% vs. 34.4%; relative risk, 0.56; 95% confidence interval [CI], 0.36 to 0.86). Progesterone was associated with a nonsignificant reduction in neonatal morbidity (8.1% vs. 13.8%; relative risk, 0.59; 95% CI, 0.26 to 1.25; P = 0.17). There were no serious adverse events associated with the use of progesterone.

CONCLUSIONS

In women with a short cervix, treatment with progesterone reduces the rate of spontaneous early preterm delivery.

Instagram
AV. Anita Garibaldi, nº 1555, Sala 105 - Centro Médico Garibaldi
CEP 40210-902, Salvador, Bahia
Telefax 71 3235-0958 / 99197-8344
Email: aloimune@aloimune.com.br
Responsável Técnico - Dr. Manoel Sarno - CREMEB - 13410
© Todos os direitos reservados - 2015 - CREMEB: 13410
Leadone